Primecap Management CO Astrazeneca PLC Transaction History
Primecap Management CO
- $118 Billion
- Q1 2025
A detailed history of Primecap Management CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Primecap Management CO holds 40,661,485 shares of AZN stock, worth $2.92 Billion. This represents 2.53% of its overall portfolio holdings.
Number of Shares
40,661,485
Previous 41,019,527
0.87%
Holding current value
$2.92 Billion
Previous $2.69 Billion
11.2%
% of portfolio
2.53%
Previous 2.12%
Shares
31 transactions
Others Institutions Holding AZN
# of Institutions
1,429Shares Held
505MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.1 Billion0.52% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.56 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.28 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.24 Billion0.47% of portfolio
-
Franklin Resources Inc San Mateo, CA21.1MShares$1.51 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $222B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...